Veradigm Debt to Equity Ratio 2012-2022 | MDRX
Current and historical debt to equity ratio values for Veradigm (MDRX) over the last 10 years. The debt/equity ratio can be defined as a measure of a company's financial leverage calculated by dividing its long-term debt by stockholders' equity. Veradigm debt/equity for the three months ending December 31, 2022 was 0.00.
| Veradigm Debt/Equity Ratio Historical Data | |||
|---|---|---|---|
| Date | Long Term Debt | Shareholder's Equity | Debt to Equity Ratio |
| 2022-12-31 | $0.49B | $1.02B | 0.48 |
| 2022-09-30 | $0.51B | $1.18B | 0.44 |
| 2022-06-30 | $0.52B | $1.20B | 0.43 |
| 2022-03-31 | $1.08B | $1.35B | 0.80 |
| 2021-12-31 | $0.95B | $1.36B | 0.70 |
| 2021-09-30 | $1.07B | $1.42B | 0.75 |
| 2021-06-30 | $1.15B | $1.39B | 0.82 |
| 2021-03-31 | $1.19B | $1.68B | 0.71 |
| 2020-12-31 | $1.25B | $1.67B | 0.75 |
| 2020-09-30 | $1.94B | $1.21B | 1.60 |
| 2020-06-30 | $1.95B | $1.24B | 1.57 |
| 2020-03-31 | $2.01B | $1.24B | 1.62 |
| 2019-12-31 | $1.92B | $1.29B | 1.49 |
| 2019-09-30 | $1.95B | $1.28B | 1.52 |
| 2019-06-30 | $1.92B | $1.32B | 1.46 |
| 2019-03-31 | $1.79B | $1.46B | 1.23 |
| 2018-12-31 | $1.60B | $1.58B | 1.01 |
| 2018-09-30 | $3.40B | $1.12B | 3.05 |
| 2018-06-30 | $3.21B | $1.14B | 2.81 |
| 2018-03-31 | $3.26B | $1.11B | 2.94 |
| 2017-12-31 | $3.07B | $1.16B | 2.65 |
| 2017-09-30 | $2.74B | $1.15B | 2.39 |
| 2017-06-30 | $2.62B | $1.17B | 2.25 |
| 2017-03-31 | $2.61B | $1.19B | 2.20 |
| 2016-12-31 | $2.56B | $1.27B | 2.01 |
| 2016-09-30 | $2.44B | $1.37B | 1.78 |
| 2016-06-30 | $2.36B | $1.35B | 1.75 |
| 2016-03-31 | $1.24B | $1.39B | 0.89 |
| 2015-12-31 | $1.26B | $1.42B | 0.89 |
| 2015-09-30 | $1.28B | $1.40B | 0.92 |
| 2015-06-30 | $1.31B | $1.39B | 0.94 |
| 2015-03-31 | $1.23B | $1.28B | 0.96 |
| 2014-12-31 | $1.18B | $1.28B | 0.92 |
| 2014-09-30 | $1.29B | $1.28B | 1.00 |
| 2014-06-30 | $1.29B | $1.30B | 1.00 |
| 2014-03-31 | $1.33B | $1.31B | 1.02 |
| 2013-12-31 | $1.30B | $1.32B | 0.99 |
| 2013-09-30 | $1.31B | $1.33B | 0.98 |
| 2013-06-30 | $1.31B | $1.37B | 0.96 |
| 2013-03-31 | $1.29B | $1.33B | 0.97 |
| 2012-12-31 | $1.07B | $1.28B | 0.83 |
| 2012-09-30 | $1.11B | $1.30B | 0.85 |
| 2012-06-30 | $1.20B | $1.28B | 0.94 |
| 2012-03-31 | $1.06B | $1.49B | 0.71 |
| 2011-12-31 | $1.03B | $1.48B | 0.70 |
| 2011-09-30 | $0.99B | $1.44B | 0.69 |
| 2011-06-30 | $1.04B | $1.41B | 0.74 |
| 2011-03-31 | $1.02B | $1.43B | 0.71 |
| 2010-12-31 | $1.04B | $1.38B | 0.75 |
| 2010-09-30 | $1.01B | $1.37B | 0.74 |
| 2010-06-30 | $0.00B | 0.00 | |
| 2010-05-31 | $0.29B | $0.81B | 0.36 |
| 2010-03-31 | $0.00B | 0.00 | |
| 2010-02-28 | $0.24B | $0.79B | 0.31 |
| 2009-12-31 | $0.21B | $0.77B | 0.27 |
| 2009-11-30 | $0.21B | $0.77B | 0.27 |
| 2009-09-30 | $0.00B | 0.00 | |
| 2009-08-31 | $0.23B | $0.74B | 0.31 |
| 2009-05-31 | $0.25B | $0.70B | 0.36 |
| 2009-02-28 | $0.26B | $0.72B | 0.36 |
| 2008-11-30 | $0.28B | $0.71B | 0.39 |
| 2008-09-30 | $0.24B | $0.35B | 0.69 |
| 2008-08-31 | $0.00B | 0.00 | |
| 2008-06-30 | $0.23B | $0.35B | 0.67 |
| 2008-05-31 | $0.07B | $0.11B | 0.62 |
| 2008-03-31 | $0.24B | $0.34B | 0.70 |
| 2008-02-29 | $0.00B | 0.00 | |
| 2007-12-31 | $0.24B | $0.34B | 0.70 |
| 2007-11-30 | $0.00B | 0.00 | |
| 2007-09-30 | $0.17B | $0.33B | 0.50 |
| 2007-06-30 | $0.16B | $0.34B | 0.49 |
| 2007-05-31 | $0.00B | 0.00 | |
| 2007-03-31 | $0.17B | $0.32B | 0.51 |
| 2006-12-31 | $0.16B | $0.32B | 0.51 |
| 2006-09-30 | $0.16B | $0.31B | 0.52 |
| 2006-06-30 | $0.15B | $0.30B | 0.51 |
| 2006-03-31 | $0.16B | $0.29B | 0.54 |
| 2005-12-31 | $0.12B | $0.10B | 1.25 |
| 2005-09-30 | $0.11B | $0.09B | 1.22 |
| 2005-06-30 | $0.12B | $0.09B | 1.31 |
| 2005-03-31 | $0.12B | $0.08B | 1.38 |
| 2004-12-31 | $0.12B | $0.08B | 1.47 |
| 2004-09-30 | $0.11B | $0.08B | 1.49 |
| 2004-06-30 | $0.03B | $0.09B | 0.31 |
| 2004-03-31 | $0.03B | $0.09B | 0.30 |
| 2003-12-31 | $0.03B | $0.08B | 0.32 |
| 2003-09-30 | $0.03B | $0.08B | 0.31 |
| 2003-06-30 | $0.02B | $0.08B | 0.22 |
| 2003-03-31 | $0.02B | $0.08B | 0.21 |
| 2002-12-31 | $0.02B | $0.09B | 0.22 |
| 2002-09-30 | $0.02B | $0.09B | 0.20 |
| 2002-06-30 | $0.02B | $0.09B | 0.18 |
| 2002-03-31 | $0.02B | $0.10B | 0.17 |
| 2001-12-31 | $0.02B | $0.10B | 0.19 |
| 2001-09-30 | $0.02B | $0.11B | 0.18 |
| 2001-06-30 | $0.06B | $0.46B | 0.12 |
| 2001-03-31 | $0.06B | $0.49B | 0.12 |
| 2000-12-31 | $0.01B | $0.29B | 0.05 |
| 2000-09-30 | $0.02B | $0.31B | 0.05 |
| 2000-06-30 | $0.01B | $0.32B | 0.04 |
| 2000-03-31 | $0.01B | $0.18B | 0.04 |
| 1999-12-31 | $0.01B | $0.07B | 0.10 |
| 1999-09-30 | $0.01B | $0.07B | 0.10 |
| 1999-06-30 | $0.01B | $0.01B | 2.35 |
| 1999-03-31 | $0.02B | $0.01B | 2.13 |
| 1998-12-31 | $0.01B | $0.01B | 2.29 |
| 1998-09-30 | $0.00B | 0.00 | |
| 1998-06-30 | $0.00B | 0.00 | |
| 1997-12-31 | $0.03B | $-0.01B | -3.54 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $0.490B | $0.000B |
| Veradigm Inc. is a healthcare technology company which drives value through its combination of platforms, data, expertise, connectivity and scale. Its network features a dynamic community of solutions and partners providing advanced insights, technology and data-driven solutions. Veradigm Inc., formerly known as Allscripts Healthcare Solutions Inc., is based in CHICAGO. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Veeva Systems (VEEV) | United States | $24.733B | 27.19 |
| Tempus AI (TEM) | United States | $7.677B | 0.00 |
| Hims & Hers Health (HIMS) | United States | $4.429B | 38.86 |
| Doximity (DOCS) | United States | $3.888B | 16.84 |
| IRhythm Holdings (IRTC) | United States | $3.724B | 0.00 |
| 10x Genomics (TXG) | United States | $2.973B | 0.00 |
| Privia Health (PRVA) | United States | $2.810B | 131.59 |
| Hinge Health (HNGE) | United States | $2.789B | 0.00 |
| Heartflow (HTFL) | United States | $2.311B | 0.00 |
| Omnicell (OMCL) | United States | $1.564B | 43.00 |
| Inspire Medical Systems (INSP) | United States | $1.555B | 20.94 |
| Enovis (ENOV) | United States | $1.405B | 7.40 |
| Butterfly Network (BFLY) | United States | $1.047B | 0.00 |
| Azenta (AZTA) | United States | $1.023B | 41.13 |
| Clover Health Investments (CLOV) | United States | $1.013B | 0.00 |
| Talkspace (TALK) | United States | $0.864B | 103.40 |
| Schrodinger (SDGR) | United States | $0.839B | 0.00 |
| Phreesia (PHR) | United States | $0.490B | 50.38 |
| Fulgent Genetics (FLGT) | United States | $0.429B | 0.00 |
| Standard BioTools (LAB) | United States | $0.345B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.322B | 0.00 |
| CapsoVision (CV) | United States | $0.311B | 0.00 |
| Senseonics Holdings (SENS) | United States | $0.279B | 0.00 |
| Claritev (CTEV) | United States | $0.269B | 0.00 |
| TruBridge (TBRG) | United States | $0.268B | 8.60 |
| Evolent Health (EVH) | United States | $0.260B | 0.00 |
| Carlsmed (CARL) | United States | $0.239B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.196B | 0.00 |
| Zepp Health (ZEPP) | Netherlands | $0.189B | 0.00 |
| CareCloud (CCLD) | United States | $0.115B | 8.18 |
| Nyxoah SA (NYXH) | Belgium | $0.111B | 0.00 |
| Insight Molecular Diagnostics (IMDX) | United States | $0.102B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.101B | 0.00 |
| American Well (AMWL) | United States | $0.086B | 0.00 |
| Outset Medical (OM) | United States | $0.077B | 0.00 |
| Health Catalyst (HCAT) | United States | $0.073B | 0.00 |
| Pulmonx (LUNG) | United States | $0.058B | 0.00 |
| 111 (YI) | China | $0.057B | 0.00 |
| NetraMark Holdings (AINMF) | Canada | $0.052B | 0.00 |
| Precipio (PRPO) | United States | $0.049B | 0.00 |
| HeartBeam (BEAT) | United States | $0.047B | 0.00 |
| Evaxion - (EVAX) | Denmark | $0.034B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.020B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.018B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.017B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.011B | 0.00 |
| Lunai Bioworks (LNAI) | United States | $0.009B | 0.00 |
| Zhongchao (ZCMD) | China | $0.008B | 0.00 |
| HeartSciences (HSCS) | United States | $0.007B | 0.00 |
| ITonic Holdings (ITOC) | China | $0.005B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.003B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.002B | 0.00 |
| PROFUSA (PFSA) | United States | $0.001B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.001B | 0.00 |